Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in RAPP — Rapport Therapeutics, Inc.

CIK 1595888 NEW YORK, NY
Back to RAPP Full portfolio

Position in RAPP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,321,226
+$2,321,226 QoQ
Shares Held
55,705
Ownership
0.116%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 159 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RAPP Over Time

Shares Held

Position Value (USD)

Derivatives in RAPP

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$208,350
PutShares
5,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,861,470 across 292 Biotechnology names. RAPP ranks #58 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in RAPP

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $208,350 5,000
2026-06-30 $2,321,226 55,705
2025-12-31 $788,840 26,000
2025-09-30 $1,517,670 51,100
2025-09-30 $5,527,170 186,100
2025-09-30 $1,372,823 46,223